Valuation

Halozyme Therapeutics, Inc. Valuation

Valuation for Halozyme Therapeutics, Inc. (HALO) on 6ix covers company data, market context, news, risks, and AI research briefs.

websiteHALOValuation/analysis/HALO/valuation

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to HALO.

Stock profile

Ticker

HALO

Asset type

Stock

Market cap

$8.24B

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Halozyme Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • HALO primary listing
  • RV7
  • A0DLHS
  • 0J2O
  • 1HALO

Research sections

Valuation

Review valuation context for Halozyme Therapeutics, Inc..

Future growth

Review future growth context for Halozyme Therapeutics, Inc..

Past performance

Review past performance context for Halozyme Therapeutics, Inc..

Financial health

Review financial health context for Halozyme Therapeutics, Inc..

Dividend

Review dividend context for Halozyme Therapeutics, Inc..

Management

Review management context for Halozyme Therapeutics, Inc..

Ownership

Review ownership context for Halozyme Therapeutics, Inc..

Other information

Review other information context for Halozyme Therapeutics, Inc..

Community

Review community context for Halozyme Therapeutics, Inc..